You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. A Bedside Relational Agent to Improve Hematopoietic Cell Transplantation Outcomes in Cancer Patients

    SBC: CARE.COACH CORPORATION            Topic: 101

    Abstract Deliriuma major cause of fallscan occur in as many asof cancer patients undergoing stem cell transplantationresulting in up totimes greater chance of dyingDelirium risk can be mitigated and many other outcomes of stem cell transplants can be improved through behavioral interventions delivered at the bedside through conversationimageryand audioHowevertraditional means of delivering these i ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  2. A Better Mechanism for Controlled Nanopore Translocation

    SBC: ELECTRONIC BIOSCIENCES, INC.            Topic: 172

    Project Summary Enabling high accuracy nanopore based strand sequencing has the potential to improve the understanding of long range genomic relationships and processes andbased on its accessibilityenable the associated clinical and diagnostic applicationsthe fastest growing sequencing sectorUnfortunatelyit is commonplace for nanopore sequencing error rates to exceedand higher accuracy is needed t ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  3. A Clinical Study of Latiglutenase as a Treatment for Symptom Reduction for Celiac Disease

    SBC: IMMUNOGENICS LLC            Topic: NIAID

    Project Summary AbstractThe goal of this work is to develop a therapeutic drug that will protect individuals with celiac diseaseCDfrom intestinal and symptomatic distress they suffer due to minute ingestion of gluten proteinCD is an autoimmune disorder affecting the small intestineafflicting aboutof the world s populationfor which there is no known cureCurrently the only therapeutic option to avoi ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  4. A Clinical Study of Latiglutenase as a Treatment for Type 1 Diabetics with Celiac Disease

    SBC: IMMUNOGENICS LLC            Topic: 300

    Project Summary The goal of this work is to evaluate the efficacy of a therapeutic agent for protecting individuals with TypediabetesT Dand celiac diseaseCDfrom intestinal and symptomatic distress they suffer due to minute ingestion of gluten proteinBoth T D and CD are lifelong autoimmune diseases whose management is anchored upon very restrictive and distinct dietsThe co morbidity of these two di ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  5. A CLOSED LOOP ANESTHESIA DELIVERY SYSTEM

    SBC: Rodder Instruments            Topic: N/A

    N/A

    SBIR Phase I 1985 Department of Health and Human Services
  6. ACTIVE ELECTRODE HAT FOR EEG IMAGING OF SCHIZOPHRENICS

    SBC: SAM TECHNOLOGY, INC.            Topic: N/A

    N/A

    SBIR Phase I 1987 Department of Health and Human Services
  7. A dual histone deacetylase and glycogen synthase kinase 3 beta inhibitor for treating pancreatic adenocarcinoma

    SBC: Avenzoar Pharmaceuticals, Inc.            Topic: 102

    ABSTRACT Pancreatic cancer is a disease with no effective treatmentIt s low five year survival rateestimated at betweenandranks it the fourth highest of cancer related of death in the U Sdespite being the twelfth most common type of cancerEach year in the U Sthere are nearlynew cases and more thandeaths caused by the diseaseBypancreatic cancer is expected to be the second most common cancer relate ...

    STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  8. Advanced Production of High Purity Radioisotopes for Nuclear Medicine

    SBC: Purist Inc            Topic: 400

    Project Summary Abstract ! The availability of reactor produced radioisotopes relies significantly on aging foreign resourcesleading to an uncertainty in the future supply of these lifesaving radioactive ingredientsThe long term goal of this effort is development of a platform technology that can be implemented in existing research reactor infrastructure nationwide for local medical grade radioiso ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  9. A First-in-Class Human Antibody Therapeutic for Treatment of Cushing's Disease

    SBC: ELIXERA, INC.            Topic: 200

    Cortisol is a steroid hormone that regulates a wide range of processes throughout the bodyincluding metabolism and the immune responseIt also has a very important role in helping the body respond to stressHigh levels of adrenocorticotropic hormoneACTHin the adrenal glands stimulate the secretion of cortisolcausing blood levels of cortisol to riseToo much cortisol for a long period of time leads to ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  10. A functional assay for ex vivo determination of drug susceptibility for multiple myeloma patients

    SBC: TRAVERA, INC.            Topic: 102

    Multiple myeloma is the second most common hematological malignancy and remains incurablewithof patients surviving less thanyearsPatient relapse is inevitable despite an increase in therapeutic optionshighlighting the significant need for predictive biomarkers that can rapidly and accurately determine tumor drug susceptibility to direct utilization of optimal therapiesWe will apply Travera s mecha ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government